Curis Inc. said it intends to cut employees and expenses as part of its effort to realign research and development programs to focus on signaling pathways and stem cell technology. (BioWorld Today)
NeoGenesis Pharmaceuticals Inc. said Thursday it will use its chemical genomics technologies to identify therapeutic agents for infectious diseases in a multiyear collaboration with Aventis Pharma SA. (BioWorld Today)
NeoGenesis Pharmaceuticals Inc. said Thursday it will use its chemical genomics technologies to identify therapeutic agents for infectious diseases in a multiyear collaboration with Aventis Pharma SA. (BioWorld Today)
Following receipt of an approvable letter from the FDA, United Therapeutics Corp. said its orphan drug for pulmonary arterial hypertension should reach the market sometime in the next two months. (BioWorld Today)
